← Open Payments lookup

CHARLES HORTENSTINE: Open Payments

NPI 1861028466 · ATHENS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$506 in 21 payments from 13 companies in 2025. Trend: 2023 $398 · 2024 $167 · 2025 $506

Food & beverage: $463Education: $43
CompanyPaymentsAmount
ABBVIE INC.6$157
PFIZER INC.4$83
AstraZeneca Pharmaceuticals LP1$43
Blueprint Medicines Corporation1$36
Regeneron Healthcare Solutions, Inc.1$32
GlaxoSmithKline, LLC.1$28
Merck Sharp & Dohme LLC1$23
Lilly USA, LLC1$19
ADC THERAPEUTICS AMERICA, INC.1$19
Legend Biotech USA Inc.1$18

Products named: VENCLEXTA, IBRANCE, ENHERTU, AYVAKIT, IMBRUVICA, LIBTAYO, OJJAARA, KEYTRUDA.

Industry payments across GA — which companies pay providers there.